Trending News
Search results for: "Weight loss". 9 articles found.
Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear. A large real-world study of nearly 8,000 patients found that most people who discontinue these drugs manage to keep the weight off or even continue losing by restarting treatment, switching medications, or adopting lifestyle changes. While earlier clinical trials suggested rapid weight regain, this new evidence paints a more hopeful picture.
The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks. Novo Nordisk...
Khloe Kardashian is keeping it real about her weight loss transformation. While detailing her at-times unhealthy relationship with food, the Kardashians star reflected on her journey to shedding...
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.
Lilly's experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
Researchers find snake metabolite that suppresses appetite of obese mice without some of side-effects' of GLP-1 drugs Pythons follow the ultimate crash diet, swallowing an antelope in a single sitting and then going for months without eating. Now scientists have identified a molecule that appears to be crucial for this metabolic feat, and which they say could pave the way for a new class of obesity drugs. When the python metabolite, which spikes in their blood after eating, was given to obese...
Drugs used for weight loss could help reduce anxiety and depression, a new study revealed.
GET IN TOUCH
About
Snips is the first performance-based influencer marketing platform that empowers influencers with business tools to grow their audience and monetize their social networks, while enabling brands to run performance-driven influencer programs built on true measurability & scale.